O. Khyzhnyak

EP1012 - ECE_2488 - Efficacy of recombinant human growth hormone therapy in patients with Schaaf-Yang syndrome

Schaaf-Yang syndrome (SYS) is an autosomal dominant multisystem disorder with early clinical overlap with Prader–Willi syndrome. Key features include hypotonia, joint contractures, autism spectrum disorders, intellectual disability, and growth retardation. The feasibility and efficacy of recombinant human growth...